project id: TCGA-KIRC; case submitter id: TCGA-MM-A84U; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.76; rna integrity number: 7.9; age at index: 58; days to birth: -21375; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1955; age at diagnosis: 21375; ajcc clinical m: MX; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 700.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8310/3; primary diagnosis: Clear cell adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: Yes; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 178; initial weight: 70.0; sample id: e2121761-9955-4413-8711-3fb9d7e7352a; sample submitter id: TCGA-MM-A84U-01A; portion id: d2cd7dd4-a3a6-4e55-bbe8-5485cc69e5de; portion submitter id: TCGA-MM-A84U-01A-11; slide id: 7531c2d5-6d02-45e3-b56b-b2bbe85ff949; slide submitter id: TCGA-MM-A84U-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;